Skip to content

Clinical trials

Phase 2 Reperfusion Injury trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reperfusion Injury Phase: Phase 2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20082
20091
20121
20171
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Withdrawn2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dompé Farmaceutici S.p.A2
Westat2
Alavita Pharmaceuticals Inc1
Johns Hopkins University1
Kaiser Permanente1
Medicure1
Stealth BioTherapeutics Inc.1
University of Alabama at Birmingham1
Y's Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reperfusion Injury11
Acute Kidney Injury3
Hemorrhage2
Diabetes Mellitus1
Insulin Resistance1
Ischemia1
Kidney Diseases1
Myocardial Ischemia1
Neurologic Manifestations1
ST Elevation Myocardial Infarction1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.